FDA Inspection
Baxter Oncology GmbHBaxter Oncology GmbH – FDA Inspection, Aug 27, 2024
Record Details
This FDA Inspection record concerns Baxter Oncology GmbH, with an inspection on August 27, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 8f606d21-cc2a-4cf4-813d-420b7e93dccc
Inspection Facts
- Inspection number
- 1249702
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Baxter Oncology GmbH
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2025 | OAI | Office of Inspections and Investigations | Drug Quality Assurance |
| May 3, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 29, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 3, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Baxter Oncology GmbH
- FDA Inspection 1283802 - 2025-09-26
- FDA Inspection 1206312 - 2023-05-03
- FDA Inspection 1161093 - 2020-01-29
- FDA Inspection 1106642 - 2019-09-03
- FDA Inspection 1056958 - 2018-06-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.